{"disease":{"id":"delta-9-tetrahydroncannabinol","name":"delta 9 tetrahydroncannabinol"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03206463","title":"Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Yale University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}